[1]
“Combination of Sofosburvir and Daclatsvir in the treatment of Hepatitis C Genotype 2 and Genotype 3”, mfm, vol. 32, no. 4, Apr. 2024, Accessed: Dec. 26, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/1915